Skip to main content
. 2017 Jul-Sep;20(3):287–296. doi: 10.4103/aca.ACA_60_17

Table 4.

Outcome of patients with and without postcardiotomy ventricular dysfunction

Outcome All (n=222) PCVD (n=63) No PCVD (n=159) P
Mortality 9 (4.5) 8 (12.7) 1 (0.6) <0.001°
 AVR 2 (1.9) 2 (6.7) 0 0.077°
 CABG 3 (3.7) 3 (14.3) 0 0.016°
 Combined surgery 4 (11.8) 3 (25.0) 1 (4.6) 0.115°
Cardiovascular complications
 Atrial fibrillation 98 (44.1) 34 (54.0) 64 (40.3) 0.064
 Low cardiac output syndrome 35 (15.8) 24 (38.1) 11 (6.9) <0.001
 Myocardial infarct 31 (14.0) 19 (30.2) 12 (7.6) <0.001
 Stroke 10 (4.5) 2 (3.2) 8 (5.0) 0.729
 Troponin I (day 1) (µg/L) 3.4 (1.8-6.4) 5.3 (3.0-14.3) 3.1 (1.6-5.8) <0.001§
Respiratory complications
 Atelectasis 76 (34.2) 31 (49.2) 45 (28.3) <0.001
 Pneumonia 20 (9.0) 13 (20.6) 7 (4.4) <0.001
 Ventilation >24 h 95 (42.8) 44 (69.8) 51 (32.1) <0.001
Renal dysfunction
 Reduction in GFR >25% 44 (19.8) 20 (31.8) 24 (15.1) 0.005
Surgical complications
 Bleeding 38 (17.1) 16 (25.4) 22 (13.8) 0.039
 Need for redo surgery 17 (7.7) 7 (6.3) 10 (11.1) 0.771
 Length of stay (days)
 ICU 3 (2-5) 5 (3-11) 3 (2-4) <0.001§
 Hospital 15 (12-21) 20 (15-27) 14 (11-17) <0.001§

Data given as n (%) unless otherwise indicated. Chi-squared tests were used for statistical tests unless otherwise indicated. Data given as median (range), §Wilcoxon rank sum test, °Fisher’s exact test. PCVD: Postcardiotomy ventricular dysfunction, CABG: Coronary artery bypass surgery, AVR: Aortic valve replacement, GFR: Glomerular filtration rate, ICU: Intensive Care Unit